Timolol-Latanoprost recall: Subpotent
Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
Why was Timolol-Latanoprost recalled?
Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 06272022@3, Exp. date 11/24/2022 Lot # 08302022@1, Exp. date 01/27/2023
- Product
- Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.
- Recalling firm
- ImprimisRx NJ
- Quantity
- 960 bottles
- Distribution
- Nationwide in the USA
- Recall date
- November 23, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)